Supply chain shortages have dominated headlines for several months, and the pharma industry has been ... mass seizure, consent decree(s), Application Integrity Policy (AIP) prosecution and import ...

The Delhi High Court is reviewing RHC Healthcare's challenge to the 'Fortis' trademark sale to Fortis Healthcare, alleging ...

Since the city’s consent decree was entered more than six years ago, the independent monitoring team has often stressed that the Chicago Police Department must bolster its data collection and ...

A federal judge on Thursday terminated two sections of the consent decree governing the Baltimore ... “well over the industry national average of 5%,” according to the motion.

BALTIMORE (WBFF) — A federal court Judge has granted a motion for partial termination of the consent decree. The Department of Justice called it a major milestone reached by the City of ...

Columbia University acting president Claire Shipman emphasized the importance of maintaining institutional autonomy in a message Monday night that seemed to tacitly reject a potential consent decree ...

The latest report of the Aurora consent decree said the Aurora Police Department is on the right track, improving its policies. The report used a violent traffic stop in 2021 involving a Black ...

has claimed that following the government decision to deregulate the pharma industry, the sectoral exports have witnessed a 52 per cent increase within a year. This was stated by Chairman PPMA ...

As tariff threats and FDA staff cuts thrust the biopharma world into uncharted waters, President Donald Trump is offering the ...

Kennedy Jr., to reduce the influence of the pharmaceutical industry. Makary announced the change during his first interview as commissioner, with former Fox News host Megyn Kelly. He spent much of ...

Baltimore Police building relationships through community policing 02:40 Baltimore Police (BPD) asserts that community policing is one of their top priorities, especially with it being one of the ...

Johnson & Johnson is holding its earnings outlook steady despite President Donald Trump moving decisively toward imposing tariffs on the pharmaceutical industry. The administration’s ...